Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

646
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
646
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.4K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.4K
Inhaled Medications01:23

Inhaled Medications

636
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
636
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.1K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.1K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

929
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
929
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.0K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corticosteroid treatment for post-COVID-19 persistent interstitial lung disease: a randomized clinical trial.

The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases·2026
Same author

Airway structural involvement detected by quantitative computed tomography in controlled and uncontrolled asthma.

BMC pulmonary medicine·2026
Same author

Allergic Rhinitis in the Elderly. In Collaboration With the ARIA Guidelines.

The journal of allergy and clinical immunology. In practice·2026
Same author

Multi-country IgE reactivity determination of isoforms of the <i>Blomia tropicalis</i> mite allergen Blo t 2 revealed a potential biomarker of asthma severity.

Frontiers in immunology·2026
Same author

Availability and Costs of Allergic Rhinitis Treatments Across the World: A Survey of ARIA Experts.

Allergy·2026
Same author

Allergic Rhinitis and Its Impact on Asthma (ARIA)-EAACI Guidelines-2024-2025 Revision: Part II-Guidelines on Oral and Ocular Treatments.

Allergy·2026

Related Experiment Video

Updated: Dec 24, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.3K

Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal

Marcelo Bezerra de Menezes1, Eduardo Vieira Ponte2, Cintia Fernanda Bertagni Mingotti2

  • 1Department of Medicine, Medical School of Ribeirão Preto, University of São Paulo, Brazil.

Respiratory Medicine
|April 7, 2020
PubMed
Summary

Government provision of inhaled corticosteroids (ICS) in Brazil correlated with fewer asthma hospitalizations from 2008 to 2015. Increased ICS access and physician numbers were linked to reduced asthma admissions, particularly in younger age groups.

Keywords:
AsthmaHospital admissionsInhaled corticosteroidsPublic health policy

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.3K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

Related Experiment Videos

Last Updated: Dec 24, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

41.3K
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.3K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.9K

Area of Science:

  • Public Health
  • Respiratory Medicine
  • Health Policy

Background:

  • Asthma remains a significant cause of hospital admissions globally.
  • Understanding the impact of public health interventions on chronic disease management is crucial.
  • Government-led initiatives for medication provision can influence health outcomes.

Purpose of the Study:

  • To analyze trends in asthma-related hospital admissions in Brazil between 2008 and 2015.
  • To assess the relationship between these admission trends and the availability of inhaled corticosteroids (ICS) provided by the government.

Main Methods:

  • Utilized Brazilian government data to track hospital admission rates for asthma.
  • Calculated rates of ICS provision per capita, alongside physician and hospital bed numbers.
  • Employed Poisson Multilevel Regression Analyses to determine associations, adjusting for healthcare infrastructure variables.

Main Results:

  • ICS provision per 100,000 inhabitants significantly increased from 2008-2015.
  • Hospital admissions for asthma decreased, especially in age groups 5-14 and 15-39 years.
  • Increased ICS availability and physician numbers were associated with reduced asthma hospitalizations.

Conclusions:

  • Government provision of ICS demonstrated a significant association with decreased asthma hospital admissions at both municipal and national levels in Brazil.
  • Public health strategies focusing on medication access can effectively mitigate asthma-related healthcare burdens.